| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |